RNA Structure Change Sensors
Research Tool / Drug Discovery
DevelopmentActive
Key Facts
About Lucerna
Lucerna Technologies is a private, early-stage biotech company specializing in RNA-targeted research tools and drug discovery platforms. Its core intellectual property is the Spinach™ technology, an RNA aptamer system that fluoresces upon binding small-molecule dyes, allowing researchers to image and track RNA in real-time within living cells. The company has successfully commercialized research reagents, secured SBIR grant funding, and completed custom R&D projects for major pharmaceutical companies. Lucerna's strategic focus is on providing enabling tools to accelerate the identification and development of novel RNA-targeted therapeutics, particularly in splicing modulation and antiviral drug discovery.
View full company profileTherapeutic Areas
Other Research Tool / Drug Discovery Drugs
| Drug | Company | Phase |
|---|---|---|
| Brain Organoids for Drug Screening | Eureka Biotechnology | Pre-clinical |
| Heart Organoids for Drug Screening | Eureka Biotechnology | Pre-clinical |